{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T03:52:22Z","timestamp":1775620342303,"version":"3.50.1"},"reference-count":49,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100031022","name":"Center for Cancer Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100031022","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Oncology Nursing"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.soncn.2026.152174","type":"journal-article","created":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T20:29:32Z","timestamp":1773692972000},"page":"152174","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Quality and Safety Imperatives in the Identification and Management of Hereditary Cancer Syndromes"],"prefix":"10.1016","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2354-6810","authenticated-orcid":false,"given":"Kathleen","family":"Calzone","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suzanne M.","family":"Mahon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia","family":"Friend","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.soncn.2026.152174_bib0001","doi-asserted-by":"crossref","DOI":"10.3390\/genes14051025","article-title":"Hereditary cancer syndromes: a comprehensive review with a visual tool","volume":"14","author":"Garutti","year":"2023","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.soncn.2026.152174_bib0002","unstructured":"National Comprehensive Cancer Network. Genetic\/familial high-risk assessment: breast, ovarian, pancreatic, and prostate. Version 1. 2026. 2025 [cited 2025 9\/1\/2025]; Available from: https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/genetics_bopp.pdf."},{"issue":"6","key":"10.1016\/j.soncn.2026.152174_bib0003","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1097\/JU.0000000000004190","article-title":"Clinician-reported management recommendations in response to universal germline genetic testing in patients with prostate cancer","volume":"212","author":"Shore","year":"2024","journal-title":"J Urol"},{"issue":"17","key":"10.1016\/j.soncn.2026.152174_bib0004","doi-asserted-by":"crossref","first-page":"3100","DOI":"10.1200\/JCO.22.02833","article-title":"Universal germline and tumor genomic testing needed to win the war against cancer: genomics is the diagnosis","volume":"41","author":"Subbiah","year":"2023","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.soncn.2026.152174_bib0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejon.2024.102766","article-title":"Anybody who can clarify or humanize the experience would be such a help\": an interpretive description of perceptions of genomic health and nursing care in individuals with cancer predisposition syndromes","volume":"74","author":"Puddester","year":"2025","journal-title":"Eur J Oncol Nurs"},{"issue":"2","key":"10.1016\/j.soncn.2026.152174_bib0006","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.cnur.2024.12.010","article-title":"Building a genomic foundation: competencies for applying genomics in oncology nursing practice","volume":"60","author":"Dickman","year":"2025","journal-title":"Nurs Clin North Am"},{"issue":"1","key":"10.1016\/j.soncn.2026.152174_bib0007","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3390\/curroncol32010014","article-title":"Building a genomics-informed nursing workforce: recommendations for oncology nursing practice and beyond","volume":"32","author":"Limoges","year":"2024","journal-title":"Curr Oncol (Toronto, Ont)"},{"issue":"6","key":"10.1016\/j.soncn.2026.152174_bib0008","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.mcna.2019.06.002","article-title":"Family health history: the first genetic test in precision medicine","volume":"103","author":"Bennett","year":"2019","journal-title":"Med Clin No Am"},{"issue":"4","key":"10.1016\/j.soncn.2026.152174_bib0009","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/PPO.0000000000000391","article-title":"Adverse events in genetic testing: the fourth case series","volume":"25","author":"Farmer","year":"2019","journal-title":"Cancer J"},{"issue":"1","key":"10.1016\/j.soncn.2026.152174_bib0010","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s13073-020-00819-1","article-title":"Family history assessment significantly enhances delivery of precision medicine in the genomics era","volume":"13","author":"Bylstra","year":"2021","journal-title":"Genome Med"},{"issue":"6","key":"10.1016\/j.soncn.2026.152174_bib0011","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.mcna.2019.06.002","article-title":"Family health history: the first genetic test in precision medicine","volume":"103","author":"Bennett","year":"2019","journal-title":"Med Clin North Am"},{"issue":"7","key":"10.1016\/j.soncn.2026.152174_bib0012","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1001\/jama.2019.10987","article-title":"Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer: US Preventive Services Task Force recommendation statement","volume":"322","author":"Owens","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.soncn.2026.152174_bib0013","unstructured":"National Comprehensive Cancer Network, I. Genetic\/Familial-High Risk Assessment Breast, Ovarian, Pancreatic, and Prostate Cancer Clinical Practice Guidelines in Oncology (Version 3.2025) 2025. [cited 2025 5\/13\/2025]; Available from: https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/genetics_bopp.pdf."},{"key":"10.1016\/j.soncn.2026.152174_bib0014","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.breast.2021.06.013","article-title":"Quality indicators for breast cancer care: a systematic review","volume":"59","author":"Maes-Carballo","year":"2021","journal-title":"Breast"},{"issue":"10198","key":"10.1016\/j.soncn.2026.152174_bib0015","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/S0140-6736(19)31275-9","article-title":"Family health history: underused for actionable risk assessment","volume":"94","author":"Ginsburg","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.soncn.2026.152174_bib0016","first-page":"1","article-title":"Comparison of a cancer family history collection and risk assessment tool\u2013itrunsinmyfamily\u2013with risk assessment by health-care professionals","author":"Ritchie","year":"2021","journal-title":"Public Health Genom"},{"issue":"4","key":"10.1016\/j.soncn.2026.152174_bib0017","doi-asserted-by":"crossref","first-page":"e335","DOI":"10.3747\/co.25.4042","article-title":"What characterizes cancer family history collection tools? A critical literature review","volume":"25","author":"Cleophat","year":"2018","journal-title":"Curr Oncol"},{"issue":"21","key":"10.1016\/j.soncn.2026.152174_bib0018","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1200\/JCO.24.00662","article-title":"Selection of germline genetic testing panels in patients with cancer: ASCO guideline","volume":"42","author":"Tung","year":"2024","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1016\/j.soncn.2026.152174_bib0019","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1200\/JCO.23.02225","article-title":"Germline testing in patients with breast cancer: ASCO-Society of Surgical Oncology guideline","volume":"42","author":"Bedrosian","year":"2024","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1016\/j.soncn.2026.152174_bib0020","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1200\/JCO-24-02608","article-title":"Germline and somatic genomic testing for metastatic prostate cancer: ASCO guideline","volume":"43","author":"Yu","year":"2025","journal-title":"J Clin Oncol"},{"issue":"Rr-6","key":"10.1016\/j.soncn.2026.152174_bib0021","first-page":"1","article-title":"Good laboratory practices for molecular genetic testing for heritable diseases and conditions","volume":"58","author":"Chen","year":"2009","journal-title":"MMWR Recomm Rep"},{"issue":"6","key":"10.1016\/j.soncn.2026.152174_bib0022","doi-asserted-by":"crossref","first-page":"588","DOI":"10.6004\/jnccn.2023.70013","article-title":"Laboratory selection in germline genetic testing: laboratory science matters","volume":"21","author":"Mahon","year":"2023","journal-title":"J Natl Compr Canc Netw"},{"issue":"6","key":"10.1016\/j.soncn.2026.152174_bib0023","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a036541","article-title":"Cancer genetic counseling: current practice and future challenges","volume":"10","author":"Schienda","year":"2020","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"5","key":"10.1016\/j.soncn.2026.152174_bib0024","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"issue":"6","key":"10.1016\/j.soncn.2026.152174_bib0025","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1097\/PPO.0000000000000553","article-title":"Challenges and errors in genetic testing: the fifth case series","volume":"27","author":"Farmer","year":"2021","journal-title":"Cancer J"},{"key":"10.1016\/j.soncn.2026.152174_bib0026","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.832063","article-title":"Rare disease registries are key to evidence-based personalized medicine: highlighting the European experience","volume":"13","author":"K\u00f6lker","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"4","key":"10.1016\/j.soncn.2026.152174_bib0027","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1002\/jgc4.1130","article-title":"Understanding variants of uncertain significance in the era of multigene panels: through the eyes of the patient","volume":"28","author":"Reuter","year":"2019","journal-title":"J Genet Couns"},{"issue":"35","key":"10.1016\/j.soncn.2026.152174_bib0028","doi-asserted-by":"crossref","first-page":"4129","DOI":"10.1200\/JCO.22.00303","article-title":"Cascade testing for hereditary cancer syndromes: should we move toward direct relative contact? A systematic review and meta-analysis","volume":"40","author":"Frey","year":"2022","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.soncn.2026.152174_bib0029","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s10689-024-00373-4","article-title":"Cascade genetic testing for hereditary cancer syndromes: a review of barriers and breakthroughs","volume":"23","author":"Levine","year":"2024","journal-title":"Fam Cancer"},{"issue":"2","key":"10.1016\/j.soncn.2026.152174_bib0030","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s10689-022-00316-x","article-title":"Barriers to completion of cascade genetic testing: how can we improve the uptake of testing for hereditary breast and ovarian cancer syndrome?","volume":"22","author":"Kahn","year":"2023","journal-title":"Fam Cancer"},{"issue":"6","key":"10.1016\/j.soncn.2026.152174_bib0031","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1158\/1055-9965.EPI-20-1142","article-title":"Role of DNA repair variants and diagnostic radiology exams in differentiated thyroid cancer risk: a pooled analysis of two case-control studies","volume":"30","author":"Zidane","year":"2021","journal-title":"Cancer Epidemiol Biomarkers Prev."},{"issue":"2","key":"10.1016\/j.soncn.2026.152174_bib0032","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1667\/RADE-24-00021.1","article-title":"A historical survey of key epidemiological studies of ionizing radiation exposure","volume":"202","author":"Little","year":"2024","journal-title":"Radiat Res"},{"issue":"4","key":"10.1016\/j.soncn.2026.152174_bib0033","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1136\/jmedgenet-2020-107542","article-title":"Advances in genetic technologies result in improved diagnosis of mismatch repair deficiency in colorectal and endometrial cancers","volume":"59","author":"Evans","year":"2022","journal-title":"J Med Genet"},{"issue":"3","key":"10.1016\/j.soncn.2026.152174_bib0034","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.annonc.2022.12.003","article-title":"Germline-focused analysis of tumour-detected variants in 49,264 cancer patients: ESMO Precision Medicine Working Group recommendations","volume":"34","author":"Kuzbar","year":"2023","journal-title":"Ann Oncol"},{"issue":"1","key":"10.1016\/j.soncn.2026.152174_bib0035","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-93084-0","article-title":"Identification of germline cancer predisposition variants during clinical ctDNA testing","volume":"11","author":"Stout","year":"2021","journal-title":"Sci Rep"},{"issue":"9","key":"10.1016\/j.soncn.2026.152174_bib0036","doi-asserted-by":"crossref","DOI":"10.3390\/biom15091304","article-title":"A comprehensive oncological biomarker framework guiding precision medicine","volume":"15","author":"Mokhtari","year":"2025","journal-title":"Biomolecules"},{"issue":"10","key":"10.1016\/j.soncn.2026.152174_bib0037","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.39571","article-title":"Rates and classification of variants of uncertain significance in hereditary disease genetic testing","volume":"6","author":"Chen","year":"2023","journal-title":"JAMA Netw Open"},{"issue":"11","key":"10.1016\/j.soncn.2026.152174_bib0038","doi-asserted-by":"crossref","DOI":"10.1002\/mgg3.70026","article-title":"Reclassification of two MLH1 variants of uncertain significance utilizing clinical and functional data","volume":"12","author":"Frederiksen","year":"2024","journal-title":"Mol Genet Genomic Med"},{"issue":"3","key":"10.1016\/j.soncn.2026.152174_bib0039","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1002\/jgc4.1665","article-title":"Patient uptake of updated genetic testing following uninformative BRCA1 and BRCA2 results","volume":"32","author":"Macklin-Mantia","year":"2023","journal-title":"J Genet Couns"},{"issue":"12","key":"10.1016\/j.soncn.2026.152174_bib0040","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1097\/01.gim.0000250202.06200.6d","article-title":"Uptake of BRCA1 rearrangement panel testing: in individuals previously tested for BRCA1\/2 mutations","volume":"8","author":"Shannon","year":"2006","journal-title":"Genet Med"},{"key":"10.1016\/j.soncn.2026.152174_bib0041","article-title":"Universal germline genetic testing for hereditary cancer syndromes in patients with solid tumor cancer","volume":"6","author":"Esplin","year":"2022","journal-title":"JCO Precis Oncol"},{"issue":"7","key":"10.1016\/j.soncn.2026.152174_bib0042","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1177\/0192513X231194302","article-title":"Psychosocial consequences of disclosing misattributed paternity: a narrative review","volume":"45","author":"Cerfontyne","year":"2023","journal-title":"J Fam Iss."},{"issue":"1","key":"10.1016\/j.soncn.2026.152174_bib0043","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s40246-024-00587-8","article-title":"Meta-analysis of 46,000 germline de novo mutations linked to human inherited disease","volume":"18","author":"Lopes-Marques","year":"2024","journal-title":"Hum Genom"},{"key":"10.1016\/j.soncn.2026.152174_bib0044","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2022.983668","article-title":"De novo mutations, genetic mosaicism and human disease","volume":"13","author":"Mohiuddin","year":"2022","journal-title":"Front Genet"},{"key":"10.1016\/j.soncn.2026.152174_bib0045","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.yjmcc.2021.07.004","article-title":"Clonal hematopoiesis of indeterminate potential (CHIP): linking somatic mutations, hematopoiesis, chronic inflammation and cardiovascular disease","volume":"161","author":"Marnell","year":"2021","journal-title":"J Mol Cell Cardiol"},{"issue":"8","key":"10.1016\/j.soncn.2026.152174_bib0046","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1038\/gim.2017.196","article-title":"Somatic TP53 variants frequently confound germ-line testing results","volume":"20","author":"Weitzel","year":"2018","journal-title":"Genet Med"},{"issue":"3","key":"10.1016\/j.soncn.2026.152174_bib0047","first-page":"201","article-title":"Deciphering TP53 mosaic variants on germline biomarker testing: implications for oncology nurses","volume":"29","author":"Grissom","year":"2025","journal-title":"Clin J Oncol Nurs"},{"key":"10.1016\/j.soncn.2026.152174_bib0048","unstructured":"National Human Genome Institute. Mosaicism. 2025 [cited 2025 9\/25\/2025]. Available from: https:\/\/www.genome.gov\/genetics-glossary\/Mosaicism."},{"issue":"13","key":"10.1016\/j.soncn.2026.152174_bib0049","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26136140","article-title":"Skin signals: exploring the intersection of cancer predisposition syndromes and dermatological manifestations","volume":"26","author":"Ochoa-Mellado","year":"2025","journal-title":"Int J Mol Sci"}],"container-title":["Seminars in Oncology Nursing"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0749208126000549?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0749208126000549?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T02:55:12Z","timestamp":1775616912000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0749208126000549"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":49,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S0749208126000549"],"URL":"https:\/\/doi.org\/10.1016\/j.soncn.2026.152174","relation":{},"ISSN":["0749-2081"],"issn-type":[{"value":"0749-2081","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Quality and Safety Imperatives in the Identification and Management of Hereditary Cancer Syndromes","name":"articletitle","label":"Article Title"},{"value":"Seminars in Oncology Nursing","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.soncn.2026.152174","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"152174"}}